/Zimmer%20Biomet%20Holdings%20Inc%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
With a market cap of around $16 billion, Zimmer Biomet Holdings, Inc. (ZBH) designs, manufactures, and markets orthopedic reconstructive products, sports medicine solutions, robotic technologies, and digital healthcare platforms used to treat bone, joint, and soft tissue disorders. It also offers advanced technologies such as the ROSA Robot and the ZBEdge Platform to support surgeons with data-driven insights and precision in orthopedic procedures.
Shares of the medical technology company have lagged behind the broader market over the past 52 weeks. ZBH stock has decreased 13.6% over this time frame, while the broader S&P 500 Index ($SPX) has gained 25.8%. In addition, the stock has declined 7.1% on a YTD basis, compared to SPX's 8.7% gain.